home / stock / incr.u:cc / incr.u:cc quote
Last: | $5.93 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0 |
High: | $0 |
Low: | $0 |
Volume: | 0 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.93 | $0 | $0 | $0 | $0 | 0 | 08-02-2022 |
$5.83 | $5.81 | $5.83 | $5.83 | $5.75 | 400 | 05-06-2022 |
$5.95 | $5.78 | $5.95 | $5.96 | $5.7 | 7,000 | 05-05-2022 |
$5.77 | $5.77 | $5.77 | $5.78 | $5.77 | 900 | 05-04-2022 |
$5.8 | $5.97 | $5.8 | $5.97 | $5.72 | 11,600 | 04-29-2022 |
$6.09 | $6.01 | $6.09 | $6.09 | $5.95 | 7,208 | 04-28-2022 |
$5.86 | $5.86 | $5.86 | $5.86 | $5.86 | 2,300 | 04-26-2022 |
$5.75 | $5.75 | $5.75 | $5.76 | $5.73 | 1,800 | 04-25-2022 |
$5.94 | $5.98 | $5.94 | $5.98 | $5.9 | 3,150 | 04-22-2022 |
$6.04 | $6.04 | $6.04 | $6.04 | $6.04 | 112 | 04-21-2022 |
$6.11 | $6.25 | $6.11 | $6.25 | $5.99 | 1,142 | 04-20-2022 |
$6.44 | $6.19 | $6.44 | $6.44 | $6.19 | 1,525 | 04-19-2022 |
$6.08 | $6.16 | $6.08 | $6.17 | $6 | 7,542 | 04-18-2022 |
$6.18 | $6.2 | $6.18 | $6.2 | $6.17 | 2,800 | 04-15-2022 |
$6.18 | $6.2 | $6.18 | $6.2 | $6.17 | 2,800 | 04-14-2022 |
$6.39 | $6.35 | $6.39 | $6.39 | $6.33 | 1,400 | 04-13-2022 |
$6.23 | $6.25 | $6.23 | $6.25 | $6.23 | 200 | 04-12-2022 |
$6.38 | $6.45 | $6.38 | $6.45 | $6.38 | 500 | 04-11-2022 |
$6.59 | $6.59 | $6.59 | $6.59 | $6.59 | 100 | 04-08-2022 |
$6.59 | $6.56 | $6.59 | $6.59 | $6.56 | 200 | 04-07-2022 |
News, Short Squeeze, Breakout and More Instantly...
Intercure Ltd. Ordinary Shares Company Name:
INCR.U:CC Stock Symbol:
TSXC Market:
Intercure Ltd. Ordinary Shares Website:
NEW YORK, and HERZLIYA, Israel, Oct. 17, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TASE: INCR) (dba Canndoc) (" InterCure " or the " Compan y "), the leading medical cannabis company in Israel and outside of North America, today addressed the status of the security ...
Achieved record revenues of NIS 209 million ($ 7 5 million) 1 for the first half of 2023 Annualized revenue run rate of NIS 41 7 million ($ 149 million) Adjusted EBITDA 2 of NIS 30 mill...
NEW YORK and TORONTO and HERZLIYA, Israel, June 09, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd . (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)(" InterCure " or the " Compan y "), reports today that, further to the Company’s press release issued on February 1, 2023, wh...